AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymche...
GCCL, a South Korea-based leading provider of clinical trial sample analysis, and China & US based GemPharmatech, a ...
South Korea-based Samsung Biologics has announced the launch of an all-cash public tender offer to acquire 100% of the f...
Innovent Biologics and Spero Therapeutics have entered into an exclusive licence agreement for IBI355, also known as SP0...
Japan-based Dai Nippon Printing (DNP) has signed a share purchase agreement to acquire Kyowa Pharma Chemical, an act...
The global CDMO market is moving beyond the era when manufacturing capacity alone defined competitive ...
Autolomous and Cellular Origins have announced end-to-end integration of their respective platforms, bringing full autom...
RoosterBio and Qkine have entered a distribution agreement to provide U.S. customers with a single-source platform for c...
Catalent and Nanoscope Therapeutics have expanded their partnership to support late-phase clinical development and comme...
Matica Biotechnology has entered a partnership with VaxDome to support development of antigen-agnostic antiviral-vaccine...
As antibody-drug conjugates (ADCs) transition from a promising therapeutic modality to a cornerstone of precision oncolo...
ADCs continue to represent a major growth area for drug developers, with the market projected to reach $69B by 20291. As...
Cryoport’s IntegriCell cryopreservation services have been selected by Verismo Therapeutics to support the company...
Palmer Holland has partnered with FerrinX to distribute NanoFerrin, a precision-fermented form of lactoferrin for skinca...
Sartorius and LFB Biomanufacturing have announced an expansion of their collaboration with the aim of offering biop...
Chime Biologics, a global biologics contract development and manufacturing organisation (CDMO), has announced the inaugu...
As advanced therapeutics move from scientific promise to commercial reality, the industry's focus is shifting be...
WuXi Biologics’ Suzhou Biosafety Testing Center has passed a European Medicines Agency Good Manufacturing Practice...
Niowave and Ratio Therapeutics have signed a supply agreement for Actinium-225, strengthening Ratio’s access to a ...
As cell and gene therapies advance toward commercial reality, the industry's focus is rapidly shifting beyond manufactur...
SCbio will spotlight South Carolina’s expanding life sciences sector at BIO International Convention 2026 in San D...
Chime Biologics, a China-based biologics CDMO dedicated to enabling partners’ success, and South Korea-based Daewo...
What were the key takeaways for Hongene after attending TIDES USA 2026? TIDES USA 2026 reinforced several themes that w...
The rise of advanced therapies is fundamentally reshaping the contract manufacturing landscape, pushing CDMOs to evolve ...
South Korea-based LOTTE Biologics has announced an expansion of its collaboration with UK-based Ottimo Pharma, an innova...
